PO.CL04.01 · 临床研究

衰老通过改变生长表型、衰老和分泌信号重编程结肠类器官对Braf V600E激活的早期致癌反应

Aging reprograms early oncogenic responses to Braf V600E activation in colon organoids through altered growth phenotype, senescence, and secretory signaling

编号 2461 展板 2 时间 4/20 09:00–12:00 区域 Section 41 主讲 Shilpa Bisht, PhD
分会场 Cancer and Aging: Implications for Outcomes
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Shilpa Bisht1, Kaavya Mahadevan Iyer1, Akash Sureshkumar2, Rachael Powers3, Ying Cui1, Jinxiao Liang1, Lijing Yang4, Daniel Petkovich5, Damilola Killanin6, Ray-Whay C. Yen1, Tina Largent1, Stephen B. Baylin1, Rafael de Cabo7, Hariharan P. Easwaran1

1Oncology, Johns Hopkins University School of Medicine, Baltimore, MD,2Mathematics, Emory University, Atlanta, GA,3Department of Neurology, University of Michigan, Ann Arbor, MI,4Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei, PR, China,5Champions Oncology, Rockville, MD,6National Institute of Dental and Craniofacial Research, National Institute of Health, Bethesda, MD,7Experimental Gerontology, National Institute on Aging, Baltimore, MD

摘要 Abstract

中文摘要
结直肠癌(CRC)的发病率随年龄增长而增加,然而衰老如何影响上皮细胞对致癌突变的早期反应仍知之甚少。Braf V600E突变是CRC锯齿状通路的主要驱动因素,但Braf V600E激活在衰老肠道干细胞中引发的初始分子事件在很大程度上尚未明确。在本研究中,我们使用源自年轻(2月龄)和年老(22月龄)雄性及雌性小鼠的近端结肠类器官(COs)来模拟对致癌性Braf V600E的年龄依赖性反应,这些小鼠在内源性Braf位点携带杂合的Cre可激活Braf V600E转基因(称为Braf +/LSL),并携带编码红色荧光标志蛋白TdTom的Cre可激活基因(称为TdTom +/LSL)。我们发现Braf V600E激活对上皮生长的影响因年龄而异。在Cre介导的Braf V600E诱导后,年轻雄性和雌性COs表现出明显的增殖爆发,随后在后期传代中出现急剧的生长崩溃,表明存在初始的癌基因诱导衰老(OIS)反应。相比之下,年老COs在连续传代中表现出持续生长,表明未能启动OIS程序。qPCR分析与这些表型一致:在年轻类器官中,衰老相关基因(p21、p16、Cxcl2、Il6)特异性地在第4代出现强烈诱导,与生长减弱同时发生。年老COs在所有传代中均表现出这些转录本诱导显著减弱或缺失,支持年龄相关的衰老能力丧失。衰老能力的丧失特异于癌基因反应,而非一般DNA损伤剂。分泌谱进一步区分了这些反应:年轻Braf V600E激活的COs中CXCL2和IL-6分泌增加,反映SASP激活,而年老COs产生的这些细胞因子极少。此外,与年轻对照相比,年老COs中IGF2分泌显著减少,提示生长因子信号发生改变,可能有助于在致癌应激下持续增殖。全基因组转录组和表观基因组分析表明结肠上皮中出现促肿瘤发生的表观遗传状态,包括衰老和代谢通路的紊乱。鉴于普遍认为衰老伴随干细胞衰老增加的观点,这些发现尤为重要。我们的研究揭示了一个悖论:年老上皮细胞在暴露于癌基因时表现出减弱的衰老反应。这一新颖发现表明,年老细胞绕过OIS的能力,加上炎症反应减弱,在衰老所致肿瘤起始易感性增加中起关键作用。
查看英文原文 English abstract
Colorectal cancer (CRC) incidence increases with advanced age, yet how aging affects early epithelial responses to oncogenic mutations remains poorly understood. Braf V600E mutation is a major driver of serrated pathway of CRC, but the initial molecular events caused by Braf V600E activation in aged intestinal stem cells are largely undefined. In the present study, we used proximal colon organoids (COs) derived from young (2 months) and aged (22 months) male and female mice carrying heterozygous Cre-activable Braf V600E (termed Braf +/LSL ) transgene at the endogenous Braf locus and Cre-activable gene encoding red fluorescence marker protein, TdTom (termed TdTom +/LSL ) to model age-dependent responses to oncogenic Braf V600E . We found that Braf V600E activation differentially affects epithelial growth depending on age. Following Cre-mediated Braf V600E induction, young male and female COs exhibited a pronounced proliferative burst, followed by a sharp growth collapse later passage, indicating an initial oncogene-induced senescence (OIS) response. In contrast, aged COs showed sustained growth across serial passages, indicating a failure to mount an OIS program. qPCR analysis aligned with these phenotypes: in young organoids, senescence-associated genes ( p21 , p16 , Cxcl2 , Il6 ) showed strong induction specifically at passage 4, coinciding with growth attenuation. Aged COs showed markedly reduced or absent induction of these transcripts at all passages, supporting an age-related loss of senescence competence. Loss of senescence competence is specific to oncogene response, not to general DNA damaging agents. The secretary profile further distinguished these responses with increases in CXCL2 and IL-6 secretion in young Braf V600E activated COs, reflecting SASP activation, whereas aged COs produced minimal amounts of these cytokines. Additionally, IGF2 secretion was significantly diminished in aged COs compared to young counterparts, suggesting altered growth factor signaling that may facilitate continued proliferation under oncogenic stress. Genome wide transcriptome and epigenome analyses indicate emergence of pro-tumorigenic epigenetic states in colon epithelium, which includes disrupted senescence and metabolic pathways. These findings are especially significant given the widely held view that aging is accompanied by increased stem cell senescence. Our studies reveal a paradox: aged epithelial cells exhibit a diminished senescence response when exposed to oncogenes. This novel observation reveals that the ability of aged cells to bypass OIS, together with a reduced inflammatory response, plays a key role in the increased susceptibility to tumor initiation observed with aging.
利益披露 Disclosure
S. Bisht, None.. K. M. Iyer, None.. A. Sureshkumar, None.. R. Powers, None.. Y. Cui, None.. J. Liang, None.. L. Yang, None.. D. Petkovich, None.. D. Killanin, None.. R. C. Yen, None.. T. Largent, None.. S. B. Baylin, None.. R. de Cabo, None.. H. P. Easwaran, None.

← 返回 AACR 2026 检索